Myomaker Bio

Loughborough, United Kingdom

Myomaker Bio develops lab-grown human skeletal muscle platforms for preclinical drug testing.

$434K raised

Mar 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Myomaker Bio raised?

Myomaker Bio has raised $434K in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are Myomaker Bio's investors?

Myomaker Bio's investors include SFC Capital.

Where is Myomaker Bio headquartered?

Myomaker Bio is headquartered in Loughborough, United Kingdom.

What does Myomaker Bio do?

Myomaker Bio develops lab-grown human skeletal muscle platforms for preclinical drug testing.

What stage is Myomaker Bio at?

Myomaker Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 12, 2026.

MLA

"Myomaker Bio — Funding & Investors." VCBacked, March 12, 2026, https://www.vcbacked.co/company/myomaker-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). Myomaker Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/myomaker-bio

Wikipedia (cite web)

{{cite web |title=Myomaker Bio — Funding & Investors |url=https://www.vcbacked.co/company/myomaker-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 12, 2026.